| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
218 A case of Toxic Epidermal Necrolysis secondary to combination Ipilimumab and Nivolumab therapy for Pleural Mesothelioma, successfully treated with Ruxolitinib
|
Tabbakh, Judy
|
|
|
190 |
S1 |
p.
|
artikel
|
| 2 |
24 Achieving the 28 day faster diagnosis standard
|
Drought, Judith Vicki
|
|
|
190 |
S1 |
p.
|
artikel
|
| 3 |
45 A Comparison of EBUS Data: What's changed in Five years?
|
Pink, Grace
|
|
|
190 |
S1 |
p.
|
artikel
|
| 4 |
76 Adjuvant Durvalumab post chemoradiotherapy in stage III unresectable non-small cell lung cancer: A retrospective review from the University Hospitals Bristol and Weston NHS Foundation Trusts
|
Periasamy, Manivannan
|
|
|
190 |
S1 |
p.
|
artikel
|
| 5 |
155 Advanced Practice Clinical technologist contouring GTV volumes for radical lung radiotherapy
|
Black, Sarah Louise
|
|
|
190 |
S1 |
p.
|
artikel
|
| 6 |
Editorial Board
|
|
|
|
190 |
S1 |
p.
|
artikel
|
| 7 |
39 A multi-centre analysis of the performance of EBUS-TBNA testing for comprehensive molecular profiling in non-small cell lung cancer (NSCLC)
|
Dyer, Craig
|
|
|
190 |
S1 |
p.
|
artikel
|
| 8 |
167 An evaluation of recruitment for research from a clinical Lung Cancer Screening service
|
Karavadra, Sheetal
|
|
|
190 |
S1 |
p.
|
artikel
|
| 9 |
112 A novel tool development, identifying the unmet rehabilitation needs of lung cancer patients at diagnosisa pilot study
|
Palmer, Emma
|
|
|
190 |
S1 |
p.
|
artikel
|
| 10 |
205 An update on the VIGILANCE study: Developing Circulating and Imaging Biomarkers Towards Personalised Radiotherapy in Lung Cancer
|
Home, Ashley
|
|
|
190 |
S1 |
p.
|
artikel
|
| 11 |
54 A population-based review of early-onset lung cancer patients in Northern Ireland
|
Russell, Ashleigh
|
|
|
190 |
S1 |
p.
|
artikel
|
| 12 |
137 A Randomised Controlled Feasibility Trial of Surgery versus No Surgery as Part of Multi-Modality Treatment in Stage III – N2 Non-Small Cell Lung Cancer
|
Taylor, Sally
|
|
|
190 |
S1 |
p.
|
artikel
|
| 13 |
152 A retrospective audit comparing toxicity and survival outcomes in patients who received palliative radiotherapy for NSCLC using the COVID-19 hypofractionated regime with patients treated pre-pandemic using standard RCR recommended regimes
|
Bell, Lynn
|
|
|
190 |
S1 |
p.
|
artikel
|
| 14 |
40 A Retrospective Performance Audit of the West Yorkshire and Harrogate Cancer Alliance's EBUS-TBNA Service
|
Wilkins, Thomas
|
|
|
190 |
S1 |
p.
|
artikel
|
| 15 |
130 A review of patients diagnosed with non-small cell lung cancer, stage I-II disease and a performance status of 0–1 over the past 10 years
|
Trevelyan, Gareth
|
|
|
190 |
S1 |
p.
|
artikel
|
| 16 |
132 A review of why patients with performance status 0-2 didn't receive anti-cancer treatment
|
Clayton, Karen
|
|
|
190 |
S1 |
p.
|
artikel
|
| 17 |
80 A single-centre experience of adjuvant Durvalumab in patients with Non-small cell lung cancer (NSCLC) treated with radical concurrent chemo-radiotherapy
|
Hussnain, Ali
|
|
|
190 |
S1 |
p.
|
artikel
|
| 18 |
85 Assessing tolerability and toxicity of adjuvant Osimertinib following tumour resection of early-stage EGFR-mutated non-small cell lung cancer through real-world data
|
Thalia, Afxentiou
|
|
|
190 |
S1 |
p.
|
artikel
|
| 19 |
180 Assessment of the down-stream secondary care impact of targeted lung health checks
|
Iyer, Aparna
|
|
|
190 |
S1 |
p.
|
artikel
|
| 20 |
17 A third treatment pathway: is there a place for a nurse-led Best Supportive Care service for the management of patients diagnosed with lung cancer at an acute NHS Trust?
|
Fox-Hewitt, Laura
|
|
|
190 |
S1 |
p.
|
artikel
|
| 21 |
217 Atypical pseudoprogression in non-small cell lung cancer treated with pembrolizumab.
|
Singh, Aman
|
|
|
190 |
S1 |
p.
|
artikel
|
| 22 |
8 Audit of a 3-day turnaround time for histopathology reporting in lung cancer cases
|
Winstanley, Rachael
|
|
|
190 |
S1 |
p.
|
artikel
|
| 23 |
72 Audit of Oxford University Hospitals Mesothelioma service
|
Briggs, Sarah
|
|
|
190 |
S1 |
p.
|
artikel
|
| 24 |
46 Automated Derivation of Diagnostic Criteria for Lung Cancer using Natural Language Processing on Electronic Health Records: A pilot study
|
Houston, Andrew
|
|
|
190 |
S1 |
p.
|
artikel
|
| 25 |
21 Barriers to and facilitators of patient engagement in the lung cancer pathway: An interview study exploring the impact of distance and disadvantage in an urban setting
|
Mitchinson, Lucy
|
|
|
190 |
S1 |
p.
|
artikel
|
| 26 |
44 Bronchoscopy for peripheral lung lesions in patients deemed unsuitable for transthoracic needle biopsy: experience of introducing cone beam imaging
|
Wright, Matthew
|
|
|
190 |
S1 |
p.
|
artikel
|
| 27 |
100 Cancer Research UK (CRUK) National Standardised Regimen-Specific Non-Small Cell Lung Cancer (NSCLC) Consent Forms for Systemic Anti-Cancer Therapies (SACT): Where Are We Now?
|
Cox, Lucy
|
|
|
190 |
S1 |
p.
|
artikel
|
| 28 |
165 Can Pathway Navigation increase lung cancer screening uptake? Protocol for a nested randomised controlled trial and process evaluation
|
McInnerney, Daisy
|
|
|
190 |
S1 |
p.
|
artikel
|
| 29 |
169 Can reminders improve lung cancer screening uptake amongst higher-risk populations?
|
Naidu, Sindhu Bhaarrati
|
|
|
190 |
S1 |
p.
|
artikel
|
| 30 |
27 Characteristics of lung cancer diagnosed through a Rapid Diagnostic Clinic
|
Toiber-Kent, Yarden
|
|
|
190 |
S1 |
p.
|
artikel
|
| 31 |
4 Clinical and molecular characteristics of BRAF mutant Lung Adenocarcinomas
|
Bulusu, Ramesh
|
|
|
190 |
S1 |
p.
|
artikel
|
| 32 |
94 Clinical outcomes in advanced Non-Small Cell Lung Cancer (NSCLC) with METexon 14 skipping mutation
|
Smith, Miles
|
|
|
190 |
S1 |
p.
|
artikel
|
| 33 |
78 Clinical outcomes in patients with unresectable stage III Non-Small Cell Lung Cancer (NSCLC) treated with durvalumab after chemoradiation in the United Kingdom: CODAK real-world study (NCT04667312)
|
Franks, Kevin
|
|
|
190 |
S1 |
p.
|
artikel
|
| 34 |
106 CNS Patient Stratified Follow Up (PSFU) in Oncology/ Surgical Clinics
|
Toni, Peet
|
|
|
190 |
S1 |
p.
|
artikel
|
| 35 |
110 Co-creating a psychological prehabilitation document for people preparing for lung cancer treatments
|
Dancyger, Caroline
|
|
|
190 |
S1 |
p.
|
artikel
|
| 36 |
175 Community lung health check as a screening tool for lung cancer: Outcomes after completing 24 months of nodule surveillance
|
Nayyar, Moez
|
|
|
190 |
S1 |
p.
|
artikel
|
| 37 |
200 Comparative analysis of perioperative outcomes in VATS and RATS lung resections: a retrospective audit
|
Otorkpa, Michael
|
|
|
190 |
S1 |
p.
|
artikel
|
| 38 |
49 Comparing molecular diagnostic using In-house reflex testing and Next-Generation Sequencing (NGS), A cancer alliance experience in Non-small cell lung cancer (NSCLC)
|
Heba, Hassan
|
|
|
190 |
S1 |
p.
|
artikel
|
| 39 |
53 Comparison of molecular testing strategies in non small cell lung cancer: “reflex” vs “hybrid” approaches
|
Manning, Carole
|
|
|
190 |
S1 |
p.
|
artikel
|
| 40 |
7 Concordance of MET amplification detection between FISH and NGS in NSCLC
|
John, Alexius
|
|
|
190 |
S1 |
p.
|
artikel
|
| 41 |
57 Concurrent lung tumours and mesothelioma
|
Taylor, Leah
|
|
|
190 |
S1 |
p.
|
artikel
|
| 42 |
Contents
|
|
|
|
190 |
S1 |
p.
|
artikel
|
| 43 |
10 Current challenges and delays in the lung cancer diagnostic pathway
|
Fowell, Andrew
|
|
|
190 |
S1 |
p.
|
artikel
|
| 44 |
128 90 day admissions and mortality in lung cancer patients
|
Cobben, David
|
|
|
190 |
S1 |
p.
|
artikel
|
| 45 |
190 Decision Making for Thoracic Radiotherapy and Prophylactic Cranial Irradiation in ES-SCLC Post Chemoimmunotherapy
|
Sibley, Lily
|
|
|
190 |
S1 |
p.
|
artikel
|
| 46 |
166 Description of radiological growth patterns in screen-detected lung cancers: The ASCENT study cohort
|
Khaw, Chuen Ryan
|
|
|
190 |
S1 |
p.
|
artikel
|
| 47 |
103 Developing a Pulmonary Nodule Service: The story one year on…..
|
Yates, Joanna
|
|
|
190 |
S1 |
p.
|
artikel
|
| 48 |
109 Developing the role of the Lung Cancer Nurse Specialist (CNS) to support wider Clinical Practice beyond traditional role boundaries
|
Sterry, Richard
|
|
|
190 |
S1 |
p.
|
artikel
|
| 49 |
86 Does entering clinical trials achieve better survival outcomes compared to standard of care in metastatic non-small cell lung cancer patients
|
Roy, Debashree
|
|
|
190 |
S1 |
p.
|
artikel
|
| 50 |
193 Do mobile and electronic health technologies used by people with lung cancer affect physical functioning and wellbeing? A Systematic Literature Review
|
Kirkpatrick, Suriya
|
|
|
190 |
S1 |
p.
|
artikel
|
| 51 |
141 Don't be ageist: considering the use of multimodality treatment in older adults with unresectable locally advanced Non-Small Cell Lung Cancer (NSCLC)
|
Coen, Oliver
|
|
|
190 |
S1 |
p.
|
artikel
|
| 52 |
66 Early Experiences of the Use of Combination Immunotherapy for the Treatment of Malignant Mesothelioma from 2022–2023 – Real-World Evidence of 1-Year Data from a Single UK Tertiary Cancer Centre
|
Liu, Justin KH
|
|
|
190 |
S1 |
p.
|
artikel
|
| 53 |
198 Early experience with neoadjuvant immunochemotherapy and it's safety and efficacy
|
Chandarana, Karishma
|
|
|
190 |
S1 |
p.
|
artikel
|
| 54 |
115 Early identification of functional problems and self-management support for people with thoracic cancers using an Allied Health Professional Screening Tool - An audit report
|
Sandsund, Catherine
|
|
|
190 |
S1 |
p.
|
artikel
|
| 55 |
131 Early stage lung cancer outcomes – a 10 year review of surgery and radiotherapy in patients with performance status 0-1 and Stage I and II NSCLC lung cancer
|
Trevelyan, Gareth
|
|
|
190 |
S1 |
p.
|
artikel
|
| 56 |
Copyright Page
|
|
|
|
190 |
S1 |
p.
|
artikel
|
| 57 |
129 Enhancing Assessment and Care Management for patients in Emergency Department and Inpatient Wards with an Incidental Funding of Lung Cancer – Early Pilot Project Case Studies
|
Sterry, Richard
|
|
|
190 |
S1 |
p.
|
artikel
|
| 58 |
176 Ensuring Health Equality in Lung Cancer Screening
|
Bone, Helen
|
|
|
190 |
S1 |
p.
|
artikel
|
| 59 |
157 Establishing a multidisciplinary habilitation clinic for lung cancer patients receiving radical radiotherapy
|
Wingate, Emma
|
|
|
190 |
S1 |
p.
|
artikel
|
| 60 |
145 Establishing a National Therapeutic Lung Cancer Radiographer Group (TLC Rads)
|
Wingate, Emma
|
|
|
190 |
S1 |
p.
|
artikel
|
| 61 |
119 Estimating the health benefits of introducing ctDNA next generation sequencing to the diagnostic pathway for advanced lung cancer: A modelling study
|
Navani, Neal
|
|
|
190 |
S1 |
p.
|
artikel
|
| 62 |
120 Ethnic Status and Socioeconomic Deprivation in Never Smokers Compared with Current Smokers with advanced NSCLC
|
Gabriel, Lydia
|
|
|
190 |
S1 |
p.
|
artikel
|
| 63 |
93 Evaluating real-world tepotinib-related toxicity data across five UK cancer units- A case-series
|
Thalia, Afxentiou
|
|
|
190 |
S1 |
p.
|
artikel
|
| 64 |
108 Evaluation of a Lung Cancer Nurse led clinic for the routine follow up of uncomplicated post resection lung cancer patients
|
Watkins, Emma
|
|
|
190 |
S1 |
p.
|
artikel
|
| 65 |
42 Evaluation of a novel simulator for linear and radial EBUS at University College London: The Lung Phantom
|
Mullin, Monica
|
|
|
190 |
S1 |
p.
|
artikel
|
| 66 |
43 Evaluation of invasive nodal staging practice in lung cancer
|
Teagle, Alexandra
|
|
|
190 |
S1 |
p.
|
artikel
|
| 67 |
81 Evaluation of neoadjuvant chemo-immunotherapy for operable non-small cell lung cancer: clinical outcomes and impact on service delivery
|
Abu, Taher
|
|
|
190 |
S1 |
p.
|
artikel
|
| 68 |
23 Evaluation of pulmonary rehabilitation pilot service in Inverclyde Royal Hospital
|
Ong, Zhen Shun
|
|
|
190 |
S1 |
p.
|
artikel
|
| 69 |
186 Expanding Roles and Responsibilities of Lung Cancer Nurse Specialists (LCNS) in the Doncaster and Bassetlaw Targeted Lung Health Check (TLHC) Programmes
|
Davies, Natasha
|
|
|
190 |
S1 |
p.
|
artikel
|
| 70 |
126 Exploring Real-World Treatment Patterns and Outcomes in Stage IIIA N2 Non-Small Cell Lung Cancer (NSCLC)
|
Josephides, Eleni
|
|
|
190 |
S1 |
p.
|
artikel
|
| 71 |
104 Exploring Stakeholder Perspectives Regarding the Barriers and Enablers to UK-Based Clinical Trials for Lung Cancer
|
Benjamin, Lond
|
|
|
190 |
S1 |
p.
|
artikel
|
| 72 |
207 Exploring the experiences of rural and coastal people with lung cancer and their informal carers' in accessing and engaging in treatment: A qualitative interview study
|
Cooke, Samuel
|
|
|
190 |
S1 |
p.
|
artikel
|
| 73 |
183 Exploring the impact of lung cancer screening on the source of referral of those undergoing curative surgery
|
Probyn, Ben
|
|
|
190 |
S1 |
p.
|
artikel
|
| 74 |
1 Fast-tracking NSCLC Standard of Care Genomic Testing with a Formalin-free Fresh EBUS Pathway
|
du Parcq, Persephone
|
|
|
190 |
S1 |
p.
|
artikel
|
| 75 |
47 Feasiblity of day case thoracoscopy with indwelling catheter insertion
|
Turnbull, Helen
|
|
|
190 |
S1 |
p.
|
artikel
|
| 76 |
60 First-line Nivolumab/Ipilimumab in patients with unresectable malignant pleural Mesothelioma (MPM): West of Scotland experience
|
Qaisar, Aitzaz
|
|
|
190 |
S1 |
p.
|
artikel
|
| 77 |
116 Health and Wellbeing days for Lung Cancer patients
|
Tasker, Sarah
|
|
|
190 |
S1 |
p.
|
artikel
|
| 78 |
161 Healthcare professionals’ communication practices for disclosing LDCT-detected pulmonary nodules to patients undergoing surveillance
|
Katsampouris, Evangelos
|
|
|
190 |
S1 |
p.
|
artikel
|
| 79 |
58 Healthcare professionals’ experience of nutritional management in mesothelioma: qualitative insights from the Help Meso Study
|
Dismore, Lorelle
|
|
|
190 |
S1 |
p.
|
artikel
|
| 80 |
102 Hepatitis B and HIV screening prior to first systemic anticancer therapy (SACT) in an inner-city London thoracic cancer population.
|
Buckley, Thomas
|
|
|
190 |
S1 |
p.
|
artikel
|
| 81 |
68 How do family members experience coroner or procurator fiscal involvement following a mesothelioma death?
|
Taylor, Bethany
|
|
|
190 |
S1 |
p.
|
artikel
|
| 82 |
140 How many locally advanced NSCLC patients receive Durvalumab and what are the limiting factors?
|
Sharma, Catherine
|
|
|
190 |
S1 |
p.
|
artikel
|
| 83 |
210 If at first you don't succeed…switching treatments in NTRK fusion NSCLC
|
Scott, Deborah
|
|
|
190 |
S1 |
p.
|
artikel
|
| 84 |
99 Immunotherapy follow up QIP for patients with lung cancer in West Suffolk hospital
|
Hussein Ismail, Mouhamad
|
|
|
190 |
S1 |
p.
|
artikel
|
| 85 |
59 Immunotherapy Toxicities in Real-World Use of Nivolumab & Ipilimumab in Pleural Malignant Mesothelioma: Experience from Sussex Cancer Centre
|
Lonn, Cheung
|
|
|
190 |
S1 |
p.
|
artikel
|
| 86 |
28 Impact of a Radiology cancer navigator role in conjunction with a chest reporting radiographer service on the lung cancer pathway
|
White, Jamie
|
|
|
190 |
S1 |
p.
|
artikel
|
| 87 |
97 Impact of early discontinuation of Pembrolizumab due to toxicity on survival in patients with metastatic NSCLC
|
Ugorji, Anomnimechi
|
|
|
190 |
S1 |
p.
|
artikel
|
| 88 |
173 Impact of smoking cessation duration on eligibility for lung cancer screening
|
Patrick, Tanya
|
|
|
190 |
S1 |
p.
|
artikel
|
| 89 |
105 Implementation of a Lung Cancer Nurse Specialist 2WW Remote Outpatient Triage Clinic – Optimising Patient Access and Assessment
|
Sterry, Richard
|
|
|
190 |
S1 |
p.
|
artikel
|
| 90 |
33 Implementation of a Lung Oncology Virtual Ward (VW) – Accelerating Responsiveness to Personalised Care Management
|
Sterry, Richard
|
|
|
190 |
S1 |
p.
|
artikel
|
| 91 |
26 Implementation of a neoadjuvant lung cancer treatment pathway in a regional tertiary centre
|
Succony, Laura
|
|
|
190 |
S1 |
p.
|
artikel
|
| 92 |
82 Implementing the neoadjuvant chemotherapy+Nivolumab pathway for patients with resectable Non-Small Cell Lung Cancer (NSCLC)- A single UK center experience (UHNM-Stoke On Trent)
|
Jegannathen, Apurna
|
|
|
190 |
S1 |
p.
|
artikel
|
| 93 |
212 Incidence and Outcomes of MRI-confirmed Myocarditis in Patients Receiving Immune Checkpoint Inhibitors for Lung Cancer - A Single Tertiary Centre Experience
|
So, Alfred
|
|
|
190 |
S1 |
p.
|
artikel
|
| 94 |
156 Increasing re-planning rates for radical lung radiotherapy – the role of frequent cone beam IGRT and tumour size
|
Kearney, Bernard
|
|
|
190 |
S1 |
p.
|
artikel
|
| 95 |
70 Information needs of families/friends supporting people living with mesothelioma: findings from a UK survey
|
Hargreaves, Sarah
|
|
|
190 |
S1 |
p.
|
artikel
|
| 96 |
107 Introduction of Community Thoracic Advanced Nurse Practitioner 2020–2023
|
Stockdale, Stacey
|
|
|
190 |
S1 |
p.
|
artikel
|
| 97 |
73 Ipilimumab and Nivolumab for mesothelioma: a real-world UK tertiary centre experience
|
McMahon, David John
|
|
|
190 |
S1 |
p.
|
artikel
|
| 98 |
74 Is Age A Thing? Accessing Treatment for Pleural Mesothelioma
|
Slaven, Kate
|
|
|
190 |
S1 |
p.
|
artikel
|
| 99 |
201 Is Segmentectomy Really Enough in all the Different Subtypes of Stage I Adenocarcinoma? A SEER Database Analysis
|
Wijerathne, Pradeep
|
|
|
190 |
S1 |
p.
|
artikel
|
| 100 |
153 Lattice radiotherapy (LRT): Safely Dose Escalating Palliative Radiotherapy
|
Lerner, Anna
|
|
|
190 |
S1 |
p.
|
artikel
|
| 101 |
88 Long-Term Responders to first-line single agent immunotherapy in advanced Non-Small Cell Lung Cancer. Real-world evidence from The Christie.
|
Gómez-Randulfe Rodríguez, Martín Igor
|
|
|
190 |
S1 |
p.
|
artikel
|
| 102 |
95 Lorlatinib in advanced ALK-rearranged NSCLC – real-world experience in a UK population
|
Lucas, Tylan
|
|
|
190 |
S1 |
p.
|
artikel
|
| 103 |
182 Lung cancer findings from two Targeted Lung Health Check programmes running simultaneously across different geographically close regions and NHS trusts
|
Majoram, Bethany
|
|
|
190 |
S1 |
p.
|
artikel
|
| 104 |
134 Lung cancer patients’ views, experiences of treatment and communications preferences – findings from the Global Lung Cancer Coalition's fourth annual global survey
|
McNamara, Aoife
|
|
|
190 |
S1 |
p.
|
artikel
|
| 105 |
9 Lung cancer physician grading of radiology alerted chest x-rays to optimise diagnostic pathways in a resource limited setting
|
Dean, Katrina
|
|
|
190 |
S1 |
p.
|
artikel
|
| 106 |
11 Making an accurate diagnosis of anterior mediastinal lesions: A proposal for a new diagnostic algorithm from the BTOG Thymic Interest Group
|
Robinson, Stephen
|
|
|
190 |
S1 |
p.
|
artikel
|
| 107 |
148 Management of Stage 3 Non-Small Cell Lung Carcinoma
|
Basu, Archisman
|
|
|
190 |
S1 |
p.
|
artikel
|
| 108 |
65 Mesothelioma Evolution following a Diagnosis of Benign Pleural Inflammation: A Systematic Review and Meta-Analysis
|
Neilly, Mark
|
|
|
190 |
S1 |
p.
|
artikel
|
| 109 |
71 Mesothelioma incidence, presentation and treatment in the northeast of England
|
Cheng Hong, Lim
|
|
|
190 |
S1 |
p.
|
artikel
|
| 110 |
215 Metastatic NSCLC adenocarcinoma with extremely rare EGFR exon 21 p. (Leu833_His835delinsValValLeu) mutation is clinically sensitive to Osimertinib
|
Ellis, Shawn
|
|
|
190 |
S1 |
p.
|
artikel
|
| 111 |
38 Modelling Class Dependencies for Lung Cancer Subtyping from Digitised Pathology Images
|
Batchkala, George
|
|
|
190 |
S1 |
p.
|
artikel
|
| 112 |
5 Molecular marker expression in non-small cell lung cancer (NSCLC) in Humberside
|
Roejkjaer, Eline
|
|
|
190 |
S1 |
p.
|
artikel
|
| 113 |
6 Molecular testing turn around time in NSCLC before and after NGS commissioning in Milton Keynes University Hospital- An Audit 2022–2023
|
Saleem, Faiza
|
|
|
190 |
S1 |
p.
|
artikel
|
| 114 |
139 MR-guided adaptive stereotactic ablative body radiotherapy (MRgSABR) in thoracic tumours
|
Moreno-Olmedo, Elena
|
|
|
190 |
S1 |
p.
|
artikel
|
| 115 |
194 Must lacks sensitivity as a nutrition screening in patients with lung cancer
|
Phillips, Iain
|
|
|
190 |
S1 |
p.
|
artikel
|
| 116 |
84 National Real World Study of Adjuvant Osimertinib in Resected EGFR Mutated Lung Cancer
|
Ragd Sami, Elghadi
|
|
|
190 |
S1 |
p.
|
artikel
|
| 117 |
69 New research-based resources to facilitate engagement with palliative care for patients and families living with mesothelioma
|
Hargreaves, Sarah
|
|
|
190 |
S1 |
p.
|
artikel
|
| 118 |
177 Northumbria NHS Foundation Trust Lung Cancer Screening Pilot Results
|
Bittiner, Ian
|
|
|
190 |
S1 |
p.
|
artikel
|
| 119 |
118 Occupational causes of respiratory cancers: Current and emerging trends and promoting prevention
|
Conroy, Tina
|
|
|
190 |
S1 |
p.
|
artikel
|
| 120 |
219 Oesophageal EUS-guided Pericardiocentesis: A Therapeutic Conundrum in Patient with EGFR-positive Metastatic Lung Adenocarcinoma and Posterior Pericardial Tamponade
|
So, Alfred
|
|
|
190 |
S1 |
p.
|
artikel
|
| 121 |
98 One of many clinical challenges: how best to prevent Thrombotic Events pre-era of bispecific antibodies?
|
Cristina, Lopez Escola
|
|
|
190 |
S1 |
p.
|
artikel
|
| 122 |
121 Ongoing impact of the pandemic on cancer services
|
Nixon, Rodanthe
|
|
|
190 |
S1 |
p.
|
artikel
|
| 123 |
20 Optimising cancer multi-disciplinary team decision-making in virtual meetings: recommendations from a national mixed-methods study in England
|
McInnerney, Daisy
|
|
|
190 |
S1 |
p.
|
artikel
|
| 124 |
113 Optimising physical performance and improving treatment tolerance in a lung cancer patient with comorbidities: a case study of allied health intervention across the phases of rehabilitation
|
Palmer, Emma
|
|
|
190 |
S1 |
p.
|
artikel
|
| 125 |
163 Optimising uptake of the Lung Health Check Operational Pilot within a socioeconomically deprived area of Wales
|
Coslett, Chris
|
|
|
190 |
S1 |
p.
|
artikel
|
| 126 |
150 Outcomes After Curative-Intent Radiotherapy for Lung Cancer with Driver Mutations: A Retrospective Multicentre Case-Control Study
|
Ashraf, Salman
|
|
|
190 |
S1 |
p.
|
artikel
|
| 127 |
30 Outcomes and Patient Satisfaction from an Established Virtual Lung Nodule Clinic (II) at Torbay Hospital, Devon
|
Dawson, Michael
|
|
|
190 |
S1 |
p.
|
artikel
|
| 128 |
195 Outcomes of patients with malignant central airway obstruction: an evaluation of an interventional bronchoscopy service
|
Shea, Rosalind
|
|
|
190 |
S1 |
p.
|
artikel
|
| 129 |
159 Outcomes of thoracic radiotherapy for oligoprogression after a response to Pembrolizumab in patients with advanced Non-Small Cell Lung Cancer
|
Haron, Dhania
|
|
|
190 |
S1 |
p.
|
artikel
|
| 130 |
87 Overview of patients who complete two years of chemotherapy-immunotherapy for metastatic non-small cell lung cancer in Leicester
|
Shradha, Bhagani
|
|
|
190 |
S1 |
p.
|
artikel
|
| 131 |
164 Participant recollection of recent imaging is unreliable for determining eligibility for lung cancer screening
|
Sharkey, Elizabeth
|
|
|
190 |
S1 |
p.
|
artikel
|
| 132 |
50 Patient Characteristics and Outcomes from a Pulmonary Nodule Surveillance Service
|
Ahmad, Sarah
|
|
|
190 |
S1 |
p.
|
artikel
|
| 133 |
52 Patient outcome at rapid access lung cancer clinic
|
Fowell, Andrew
|
|
|
190 |
S1 |
p.
|
artikel
|
| 134 |
151 Patient outcomes following Lung SABR: The University Hospitals Dorset Experience
|
Mackenzie, Emma
|
|
|
190 |
S1 |
p.
|
artikel
|
| 135 |
111 Patient, professional and carer experiences of communicating a lung cancer diagnosis: A systematic review of qualitative evidence
|
Cooke, Samuel
|
|
|
190 |
S1 |
p.
|
artikel
|
| 136 |
147 Patient Reported Experience of Using Electronic Patient Reported Outcome Measures (ePROMs) During and After Lung Radiotherapy. A Pilot Study
|
Bowen Jones, Sarah
|
|
|
190 |
S1 |
p.
|
artikel
|
| 137 |
170 Patients diagnosed with lung cancer through the Targeted Lung Health Check Programme have a better performance status than patients from other sources of referral, as well as earlier stage disease
|
Darley, Jay
|
|
|
190 |
S1 |
p.
|
artikel
|
| 138 |
220 Patient with T1N3M1 (liver) non-squamous NSCLC diagnosed July 2008. Subsequently confirmed EXON 18 EGFR mutation (2016) - Durable Survival, Late Effects: Learning from our patient's experiences over a 16 year period (2008 to the present)
|
Mulvenna, Paula
|
|
|
190 |
S1 |
p.
|
artikel
|
| 139 |
89 Pembrolizumab in Metastatic Non-Small Cell Lung Cancer (NSCLC): Real World Data of Patient Outcomes from a District General Hospital
|
Roberts, Christopher
|
|
|
190 |
S1 |
p.
|
artikel
|
| 140 |
127 Perceptions of Health care professionals on Sleep disturbance amongst patients with Lung Cancer – Quality Improvement project (QIP)
|
Vangara, Jaya Lakshmi
|
|
|
190 |
S1 |
p.
|
artikel
|
| 141 |
51 Percutaneous tissue sampling in thoracic oncology - are core biopsies bigger and better?
|
Maged, Hassan
|
|
|
190 |
S1 |
p.
|
artikel
|
| 142 |
37 PLB Lung Biopsy Audit (Worcestershire Acute Hospitals NHS Trust)
|
Fateh, Muhammad Ovais
|
|
|
190 |
S1 |
p.
|
artikel
|
| 143 |
34 Predictive value of PD-L1 expression IHC on histology vs. cytology-specimen in non-small cell lung cancer (NSCLC) cohort in Leicester
|
Bhagani, Shradha
|
|
|
190 |
S1 |
p.
|
artikel
|
| 144 |
184 Prevalence and clinical outcomes of thoracic aortic disease detected within a UK lung screening programme: A 5 year follow-up study
|
Kimani, Linda
|
|
|
190 |
S1 |
p.
|
artikel
|
| 145 |
55 Prevention of “on-the-day cancellation” of bronchoscopy procedures to improve waiting time for cancer patients-department based Quality Improvement initiative
|
Khalid, Usman
|
|
|
190 |
S1 |
p.
|
artikel
|
| 146 |
189 Primal Screen: Do contrast-enhanced CT staging scans add clinically significant information to patients referred from a lung cancer screening programme?
|
Randles, Victoria
|
|
|
190 |
S1 |
p.
|
artikel
|
| 147 |
168 Prioritising computed tomography (CT) scans for reporting in lung cancer screening – does this help?
|
Anandan, Lavanya
|
|
|
190 |
S1 |
p.
|
artikel
|
| 148 |
117 Prognostic factors for 90-day acute care outcomes in lung cancer patients 70 and over
|
Cobben, David
|
|
|
190 |
S1 |
p.
|
artikel
|
| 149 |
216 Prolonged Localised Inflammatory Response following Bronchoscopic Thermal Vapour Ablation Therapy mimicking Lung Cancer
|
Reid, Phil
|
|
|
190 |
S1 |
p.
|
artikel
|
| 150 |
199 Pulmonary plemorphic carcinoma: high PD-L1 expression and other clinicopathologic features of 48 resection cases
|
Kapdagli, Murat
|
|
|
190 |
S1 |
p.
|
artikel
|
| 151 |
197 Radiological Surveillance of Lung Cancer Following Resection – Comparison of Two MDTs
|
Brouns, Matt
|
|
|
190 |
S1 |
p.
|
artikel
|
| 152 |
41 Rapid on-site evaluation (ROSE) speeds up the fast investigative lung cancer diagnostic pathway
|
Fowell, Andrew
|
|
|
190 |
S1 |
p.
|
artikel
|
| 153 |
101 Real-world analysis of the impact of pemetrexed in first-line maintenance (1LM) with immunotherapy (IO) for non-squamous (NSQ) advanced/metastatic non-small cell lung cancer (a/mNSCLC) lacking targetable mutations, prior to and during the COVID-19 pandemic
|
Gomes, Fabio
|
|
|
190 |
S1 |
p.
|
artikel
|
| 154 |
91 Real World data, tolerability, and clinical outcomes in patients with advanced NSCLC treated with Sotorasib in University Hospitals Birmingham
|
Batool, Rubab
|
|
|
190 |
S1 |
p.
|
artikel
|
| 155 |
96 Real-World Evidence About Efficacy and Post-progression Outcomes of Second Line Osimertinib in EGFRm NSCLC
|
Remus Mihai, Seres
|
|
|
190 |
S1 |
p.
|
artikel
|
| 156 |
83 Real-world experience with adjuvant Durvalumab following chemo-radiotherapy: a single centre exerience in UK
|
Chowdhury, Subhra
|
|
|
190 |
S1 |
p.
|
artikel
|
| 157 |
48 Real world outcomes of a lung cancer genomic tumour advisory board: a single-centre experience in the United Kingdom
|
John, Alexius
|
|
|
190 |
S1 |
p.
|
artikel
|
| 158 |
63 Real-world outcomes of Nivlolumab-Ipilimumab combination therapy in unresectable malignant mesothelioma: Mount Vernon Cancer Centre Experience
|
Achim, Tabitha
|
|
|
190 |
S1 |
p.
|
artikel
|
| 159 |
90 Real world Time on Treatment (rwToT) of Pembrolizumab in Stage IV NSCLC—a single centre experience
|
Lobo, Diana
|
|
|
190 |
S1 |
p.
|
artikel
|
| 160 |
75 Real world toxicity data for the use of ipilimumab plus nivolumab in malignant mesothelioma
|
Harriet, McGrath
|
|
|
190 |
S1 |
p.
|
artikel
|
| 161 |
185 Reducing health inequalities in Lung cancer screening: Hull prison Targeted Lung Health Check (TLHC)
|
Clark, Michelle
|
|
|
190 |
S1 |
p.
|
artikel
|
| 162 |
144 Reducing the risk of death from PJP after radical lung cancer radiotherapy – second round QI intervention updated with early outcome data
|
Leer, Martin
|
|
|
190 |
S1 |
p.
|
artikel
|
| 163 |
204 REFINE-Lung is a multicentre phase III study to determine the optimal frequency of pembrolizumab in advanced non-small cell lung cancer (NSCLC) utilising a novel multi-arm design
|
Ghorani, Ehsan
|
|
|
190 |
S1 |
p.
|
artikel
|
| 164 |
29 Reorganising weekly rapid access lung cancer clinic into daily could help to implement best practice timed lung cancer pathway and meet faster diagnosis standard
|
Dudzevicius, Vytis
|
|
|
190 |
S1 |
p.
|
artikel
|
| 165 |
202 Retrospective analysis of rate of recurrence in Non Small Cell Lung Cancer (NSCLC) patient treated with curative surgery
|
Dutta, Jayeeta
|
|
|
190 |
S1 |
p.
|
artikel
|
| 166 |
133 Review of Advanced Lung cancer treatment in relation to the NLCA report
|
Kovvuri, Lokesh
|
|
|
190 |
S1 |
p.
|
artikel
|
| 167 |
214 Rowell Syndrome as a Paraneoplastic Manifestation of Metastatic Mesothelioma
|
Younan, Helen-Cara
|
|
|
190 |
S1 |
p.
|
artikel
|
| 168 |
206 SAFFRON: Savolitinib + Osimertinib vs Chemotherapy in EGFRm NSCLC with MET Overexpression/Amplification Post-Osimertinib
|
Lindsay, Colin
|
|
|
190 |
S1 |
p.
|
artikel
|
| 169 |
213 Selpercatinib in RET Fusion Lung Adenocarcinoma
|
Bulusu, Ramesh
|
|
|
190 |
S1 |
p.
|
artikel
|
| 170 |
203 Should interactive 3D-CT models be used as an alternative to repeat contrast computed tomography in lung cancer screening programme patients for surgical planning?
|
Ackah, Kofi James
|
|
|
190 |
S1 |
p.
|
artikel
|
| 171 |
56 Simultaneous pneumothorax and mesothelioma
|
Taylor, Leah
|
|
|
190 |
S1 |
p.
|
artikel
|
| 172 |
62 Single-centre DGH experience of using immunotherapy for malignant mesothelioma
|
Patterson, Dan
|
|
|
190 |
S1 |
p.
|
artikel
|
| 173 |
92 Single institution use of direct oral anticoagulants alongside targeted therapy for non small cell lung cancer
|
Ball, Katie
|
|
|
190 |
S1 |
p.
|
artikel
|
| 174 |
122 Social Isolation and Lung Cancer: Does This Impact the Length of Time on The Lung Cancer Pathway Or Uptake Of MDT Recommended Treatments
|
Anderson, Victoria
|
|
|
190 |
S1 |
p.
|
artikel
|
| 175 |
172 Stage and Survival of Screen Detected Small Cell Lung Cancer from the SUMMIT Study
|
Prendecki, Ruth
|
|
|
190 |
S1 |
p.
|
artikel
|
| 176 |
192 Stereotactic radiofrequency ventral posterolateral thalamotomy – an effective treatment for complex pain in lung cancer?
|
Teh, Zoe
|
|
|
190 |
S1 |
p.
|
artikel
|
| 177 |
149 Stereotactic radiosurgery (SRS) for the treatment of brain metastases: Outcomes for lung cancer patients in South Wales
|
Walters, Sarah
|
|
|
190 |
S1 |
p.
|
artikel
|
| 178 |
196 Studying the Characteristics and Outcomes of People with Lung Cancer to Implement a Prehabilitation Service Pathway–A Retrospective Study
|
Kumar, Vimal
|
|
|
190 |
S1 |
p.
|
artikel
|
| 179 |
36 Summary of data for CT-guided percutaneous lung biopsy from West Yorkshire and Harrogate Cancer Alliance in 2021
|
Ng, LiJi
|
|
|
190 |
S1 |
p.
|
artikel
|
| 180 |
136 Supporting the wellbeing of oncodriven lung cancer patients online: a qualitative study
|
Harrison, Virginia
|
|
|
190 |
S1 |
p.
|
artikel
|
| 181 |
13 Survey of patients undergoing procedures in a suspected lung cancer and pleural service
|
Probyn, Ben
|
|
|
190 |
S1 |
p.
|
artikel
|
| 182 |
142 Survival outcomes for concurrent chemo-radiotherapy (cCRT) patients in stage III lung cancer: Real world data from the northern centre for cancer care (NCCC) utilising 2 regimes.
|
Pickles, Rebecca
|
|
|
190 |
S1 |
p.
|
artikel
|
| 183 |
208 SynthEtic LEthal Cancer Therapy in mesothelioma (SELECTmeso): a molecularly stratified multi-arm phase II platform trial for patients with relapsed malignant mesothelioma
|
Hill, Kayleigh
|
|
|
190 |
S1 |
p.
|
artikel
|
| 184 |
187 Targeted Lung Health Check Programme at Frimley Health Foundation Trust
|
Gill, Sindy
|
|
|
190 |
S1 |
p.
|
artikel
|
| 185 |
181 Targeted Lung Health Check screening outcomes from invited ‘aged-in’ populations
|
Goodley, Patrick
|
|
|
190 |
S1 |
p.
|
artikel
|
| 186 |
32 Targeted social media adverts to drive attendance to a self-request chest x-ray service in Greater Manchester
|
Foxley, Alison
|
|
|
190 |
S1 |
p.
|
artikel
|
| 187 |
124 Telling patients they have lung cancer on the telephone
|
Wilson, Joanne
|
|
|
190 |
S1 |
p.
|
artikel
|
| 188 |
3 The Availability of Molecular Profiling Results at New Patient Review in NSCLC and the Impact on Patient Care
|
Church, Matt
|
|
|
190 |
S1 |
p.
|
artikel
|
| 189 |
61 The first-in-class peroxiredoxin 3 (PRX3) inhibitor RSO-021 modulates the mesenchymal and immune phenotype in mesothelioma
|
Cunniff, Brian
|
|
|
190 |
S1 |
p.
|
artikel
|
| 190 |
25 The Gloucestershire Early Lung Cancer Pathway - time for a radical approach?
|
Haggie, Rebecca
|
|
|
190 |
S1 |
p.
|
artikel
|
| 191 |
16 The impact of implanting ctDNA testing on day 0 of the lung cancer pathway in patients with advanced stage disease in Manchester
|
Ghoshal, Avik
|
|
|
190 |
S1 |
p.
|
artikel
|
| 192 |
171 The impact of introducing a Targeted Lung Health Check on oncology services at Portsmouth Hospitals University NHS Trust
|
Abraham, Miriam
|
|
|
190 |
S1 |
p.
|
artikel
|
| 193 |
135 The Impact of the Electronic Patient Record on Completion and Uploading of the Holistic Needs Assessment in Lung Cancer patients
|
Gabriel, Lydia
|
|
|
190 |
S1 |
p.
|
artikel
|
| 194 |
211 The impact of the flu vaccine on fluid volumes in a patient with mesothelioma
|
Taylor, Leah
|
|
|
190 |
S1 |
p.
|
artikel
|
| 195 |
18 The incidental pulmonary nodule; making sure that no one misses out…
|
Thakrar, Vedas
|
|
|
190 |
S1 |
p.
|
artikel
|
| 196 |
15 The Integration and Analysis of Data using Artificial Intelligence to Improve Patient Outcomes with Thoracic Diseases (DART) research programme.
|
Gleeson, Fergus
|
|
|
190 |
S1 |
p.
|
artikel
|
| 197 |
162 The LungScot study: overview of findings from a feasibility and acceptability of lung screening in Scotland
|
Cavers, Debbie
|
|
|
190 |
S1 |
p.
|
artikel
|
| 198 |
67 The mental health and well-being implications of a mesothelioma diagnosis: a mixed methods study
|
Ejegi-Memeh, Stephanie
|
|
|
190 |
S1 |
p.
|
artikel
|
| 199 |
31 The Nodules of Norfolk, Setting up a Pulmonary Nodule Pathway in a secondary care setting at the Norfolk & Norwich University Hospital – A reflective study over one year from January 2023 – January 2024
|
Smith, Charlotte
|
|
|
190 |
S1 |
p.
|
artikel
|
| 200 |
174 The prevalence and clinical outcomes of incidental thymic lesions detected through Lung Cancer Screening
|
Abdelhameed, Samar
|
|
|
190 |
S1 |
p.
|
artikel
|
| 201 |
138 Therapeutic Radiographer Led Thoracic SABR services: Optimisation of skill mix in two large northern cancer centres
|
Pickles, Rebecca
|
|
|
190 |
S1 |
p.
|
artikel
|
| 202 |
2 The role of cellular pathology departments in the improvement of turnaround times for lung adenocarcinoma biomarker testing
|
Warren, Madhuri V
|
|
|
190 |
S1 |
p.
|
artikel
|
| 203 |
114 The role of the Patient Cancer Care Coordinator in the Lung Cancer Pathway – reducing health inequalities and optimising patient access
|
Sterry, Richard
|
|
|
190 |
S1 |
p.
|
artikel
|
| 204 |
79 The routine use of Granulocyte-colony stimulating factor (G-CSF) with chemo-immunotherapy does not affect clinical outcomes in lung adenocarcinoma
|
Sophia Joanna, George
|
|
|
190 |
S1 |
p.
|
artikel
|
| 205 |
154 The 2023 Royal College of Radiologists (RCR) National re-audit of radical radiotherapy for Non small cell lung cancer (NSCLC) – changing Standards of Care in UK practice
|
McAleese, Jonathan
|
|
|
190 |
S1 |
p.
|
artikel
|
| 206 |
191 The safety profile of indwelling pleural catheters
|
Campbell, Helen
|
|
|
190 |
S1 |
p.
|
artikel
|
| 207 |
209 ThOracic Umbrella RadIotherapy STudy in stage IV NSCLC: TOURIST
|
Woolf, David
|
|
|
190 |
S1 |
p.
|
artikel
|
| 208 |
Title Page
|
|
|
|
190 |
S1 |
p.
|
artikel
|
| 209 |
77 Toxicity and outcomes for patients with resected Non-Small cell lung cancer (NSCLC) who have received adjuvant chemotherapy in Bristol
|
Jessica, Ball
|
|
|
190 |
S1 |
p.
|
artikel
|
| 210 |
12 Understanding reasons for deviation from lung cancer multidisciplinary team meeting (MDM) recommendations – an audit in a large NHS Foundation Trust
|
Yip, Kay Por
|
|
|
190 |
S1 |
p.
|
artikel
|
| 211 |
160 Updating primary care smoking records by text message in preparation for lung cancer screening in Wales
|
Eccles, Sinan
|
|
|
190 |
S1 |
p.
|
artikel
|
| 212 |
146 Using Electronic Patient-Reported Outcome Measures (ePROMs) to Monitor Symptoms and Quality of Life for Patients with Lung Cancer Undergoing Radiotherapy. A Pilot Study
|
Nuamek, Thitikorn
|
|
|
190 |
S1 |
p.
|
artikel
|
| 213 |
123 Using Prescribing Data to Estimate the Number of ALKpositive Patients Currently Living in England
|
Edmonstone, Duncan
|
|
|
190 |
S1 |
p.
|
artikel
|
| 214 |
143 Using ProKnow to explore the incidence of radiation pneumonitis in relation to GTV size in Stage III Non-Small Cell Lung Cancer (NSCLC) concurrent Chemoradiotherapy (cCRT) patients and its impact on survival. A Pilot Study
|
Stamp, AIexander
|
|
|
190 |
S1 |
p.
|
artikel
|
| 215 |
19 Utility of blood tests after completion of maintenance durvalumab after radical chemo-radiotherapy in patients with Non Small Cell Lung Cancer stage III
|
Cano Gil, Domingo Vicente
|
|
|
190 |
S1 |
p.
|
artikel
|
| 216 |
188 Utility of PET-CT for Nodal Staging in a Lung Cancer Screening cohort
|
Verghese, Priyam
|
|
|
190 |
S1 |
p.
|
artikel
|
| 217 |
178 Utility of PET-CT for nodule discrimination in the SUMMIT Study
|
Verghese, Priyam
|
|
|
190 |
S1 |
p.
|
artikel
|
| 218 |
35 Validation of published radiomics model to determine if CT parameters predict Programmed Death Ligand 1 expression in Non-Small Cell Lung Cancer
|
Manickavasagar, Thubeena
|
|
|
190 |
S1 |
p.
|
artikel
|
| 219 |
64 Variability in patient pathways and experiences of care in peritoneal mesothelioma
|
Ejegi-Memeh, Stephanie
|
|
|
190 |
S1 |
p.
|
artikel
|
| 220 |
125 VTE Risk Awareness in People with Lung Cancer in the UK: Results from a Patient-led National Survey
|
Montague, Debra
|
|
|
190 |
S1 |
p.
|
artikel
|
| 221 |
179 When should patients in remission be invited to re-enter the Targeted Lung Health Check Programme? A review of patient feedback following treatment for lung cancer
|
Majoram, Bethany
|
|
|
190 |
S1 |
p.
|
artikel
|
| 222 |
158 Who gets acute oesophagitis with radical radiotherapy for locally-advanced non-small cell lung cancer (NSCLC)?
|
Kathirgamakarthigeyan, Sangary
|
|
|
190 |
S1 |
p.
|
artikel
|
| 223 |
14 Widening access and addressing inequalities for patients with lung cancer consenting to systemic anti-cancer therapies (SACT)
|
Nally, Elizabeth
|
|
|
190 |
S1 |
p.
|
artikel
|
| 224 |
22 Widening access to ctDNA - lessons from the transformation project in Kent
|
Wakelin, Sandra
|
|
|
190 |
S1 |
p.
|
artikel
|
Tijdschrift beschrijving